Navigation Links
L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008
Date:9/8/2008

ry Washington.

Bring hope to the thousands of women and their loved ones who have been affected by this devastating disease. Join L'Oreal Paris in the fight against ovarian cancer. Hope begins with you.

About L'Oreal Paris

The L'Oreal Paris Brand Division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oreal Paris brand encompasses the four major beauty categories -- haircolor, haircare, skincare and cosmetics -- and includes such well-known brands as Preference, Excellence and Natural Match haircolors; VIVE Pro, Studio Line, and L'Oreal Kids haircare; Dermo-Expertise skincare, including Advanced Revitalift, Age Perfect, Skin Genesis, Sublime Bronze and Men's Expert; Colour Riche, True Match and Bare Naturale cosmetics collections, a portfolio of mascara including Voluminous, Double Extend and Telescopic among many others, and the HIP High Intensity Pigments line.

L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to raising awareness for ovarian cancer, which continues to build. To date, L'Oreal Paris has helped raise over $14 million dollars to further research and build awareness with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal's annual "Color of Hope" cosmetic and jewelry collections.


'/>"/>
SOURCE L'Oreal Paris
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
3. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
5. LOreal Paris Celebrates Ten Years of Hope and Healing
6. OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
7. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
8. Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
9. Comparison of venlafaxine and SSRIs in the treatment of depression
10. Comparison of antipsychotic treatments in adolescents with schizophrenia
11. Comparison of anticoagulants for angioplasty show similar outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ire/ -- The general membership of the Medical,Adv...dividuals at their Annual,Awards Dinner to be hel...k. A,Lifetime Achievement Award will also be give...vertising Hall of Fame are: , Ronald Pantello, ...osition,at Sudler & Hennessey. In 1980 he lef...
(Date:11/21/2008)...s do not cause genetic damage that can lead to dis...) -- Two popular medications for treating attentio...se genetic damage linked to an increased risk for ...y, done by researchers at Duke University Medical ...ters a previous one that reported biomarkers assoc...
(Date:11/21/2008)...e/ -- In a statewide survey, 33 physicians credent...ry at Presbyterian Hospital of Dallas were honored..." Super Doctors ." , , Each year, the publi...l Media, Inc. to survey more than 38,000 medical p... you needed medical care, which doctor would you c...
(Date:11/21/2008)...ewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE:...ts to the global orthopedic device industry and ot... Moore, President and Chief Executive Officer, and...ancial Officer, are scheduled to present at the 20...The New York Palace Hotel on Wednesday, December 3...
Breaking Medicine News(10 mins):Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
... early test of the first vaccine against hepatitis...kens many Asians and can spread// to soldiers or o... made from moth cells infected with an engineered ...palese Army soldiers who took all three doses. How...
...esota permission to use state money on all varieti... bar human cloning.// The amended proposal cleare...pment Committee on a 12-7 vote. Scientists are st... to find treatments or cures for spinal cord injur...
...apanese patients looking for organ transplantation...ent of foreign patients in Chinese hospitals, more...y and not sure of receiving transplants in their h... nation where surgeries are less costly and quicke...
...ken over as the Director General of Army's Medical...ent Medical College, Nagpur he was commissioned in...ning MD in Radio Diagnosis from Pune University in...ion Oncology from the prestigious Tata Memorial Ho...
Other Medicine News:
(Date:11/20/2008)...November 20 Arpida (SWX:...ugs Advisory Committee of the,U.S. Food and Drug ...,approval of intravenous iclaprim, an antibiotic ...ients with complicated skin and skin structure inf...cillin-resistant Staphylococcus,aureus (MRSA). ,...
(Date:11/20/2008)...0 Bionovo, Inc.,(Nasdaq...lts from the Phase 1B,clinical trial of their lea...ancer, BZL101, at the Society for Integrative Onco... Georgia. The Company,s oral presentation was sel...nted as a part of the Best of the,SIO Session on ...
(Date:11/20/2008)... Radius Health ("Radius") announced...n to its second institutional financing round, inc... and the total amount raised since the company,s i...onal investors participated in the financing, led ... Capital, The Wellcome Trust, HealthCare Ventures,...
(Date:11/20/2008)...e-FirstCall/ -- PAREXEL International Corporation ...cal services provider, today announced that it has...ory consulting and clinical research capabilities.... has locations throughout five important biopharma...ude Argentina, Brazil, Chile, and Mexico. This exp...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Emageon Receives Best in KLAS Cardiology PACS Award 15216 1Emageon Receives Best in KLAS Cardiology PACS Award 15216 2QMed Inc Reports Year End and Fourth Quarter Results 15213 1QMed Inc Reports Year End and Fourth Quarter Results 15213 2QMed Inc Reports Year End and Fourth Quarter Results 15213 3QMed Inc Reports Year End and Fourth Quarter Results 15213 4QMed Inc Reports Year End and Fourth Quarter Results 15213 5QMed Inc Reports Year End and Fourth Quarter Results 15213 6QMed Inc Reports Year End and Fourth Quarter Results 15213 7Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 1Best Practice Database 3A Complimentary Excerpt of Scientific Publications Strategy Study 15210 2NCPA Statement on Californias Delay of E Pedigree Implementation 15207 1NCPA Statement on Californias Delay of E Pedigree Implementation 15207 2
...LAINATE, Italy - July 4, 2007 - Cosmo Pharmaceutic...inary results from its,phase II/III study with CB-...ea. CB-01-11 is a broad spectrum, semi-synthetic,a...t form. Through,the use of Cosmo,s MMX(tm) technol... colon, bacteria in the gastro intestinal tract,th...
...is weeks issue of Science,researchers from the Na...(NIEHS) and Umeö University in Sweden report ...hat an enzyme called,DNA polymerase epsilon plays ...st and perhaps even humans. , The study places us ...nome instability that underlie certain environment...
Other Medicine Technology:Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 3
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: